SCHEMBL256203

SCHEMBL256203

CC(C)(C)c1ccc(N)c(N)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.64
KMT2A Q03164 3/20 0.64
MEN1 O00255 2/20 0.64
MAPT P10636 2/20 0.64
GAA P10253 1/20 0.64
PKM P14618 1/20 0.64
RECQL P46063 1/20 0.64
TDP1 Q9NUW8 4/20 0.46
ALOX15 P16050 3/20 0.46
HPGD P15428 2/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP3A4 P08684 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 2/20 0.46
THRB P10828 1/20 0.46
POLB P06746 1/20 0.42
TSHR P16473 2/20 0.42
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29377581 1.00 ALDH1A1 (0.64) ALDH1A1KMT2AMEN1MAPTGAA
Hydrochloric Acid SCHEMBL8878556 0.97 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL30001931 0.84 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL687110 0.84 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL6780538 0.82 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL11400597 0.82 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL31296371 0.82 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL18199870 0.81 KMT2A (0.61) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL31556339 0.80 ALDH1A1 (0.48) ALDH1A1KMT2AMEN1MAPTGAA
SCHEMBL31556338 0.80 ALDH1A1 (0.48) ALDH1A1KMT2AMEN1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117288876-A Mass spectrum detection method for measuring concentration of formic acid in human plasma 苏州澄耀生物科技有限公司 2023-12-26 CN claimed
CN-116063238-A Java oxine compound and preparation method thereof 上海交通大学 2023-05-05 CN claimed
CN-115974796-A Woxine medicinal molecule and preparation method thereof 上海交通大学 2023-04-18 CN claimed
US-20130211168-A1 CATALYTIC COMPOSITION AND PROCESS FOR OLIGOMERIZATION OF OLEFINS USING SAID CATALYTIC COMPOSITION IFP Energies Nouvelles (FR) 2013-08-15 US claimed
EP-4656773-A1 ETHYLENE PRODUCTION METHOD, CARBON DIOXIDE REDUCTION ELECTRODE, AND CARBON DIOXIDE REDUCTION APPARATUS Sumitomo Chemical Company, Limited (JP) 2025-12-03 EP disclosed
US-20250059189-A1 PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS XENON PHARMACEUTICALS INC. (CA) 2025-02-20 US disclosed
EP-4479389-A1 ELECTROCHEMICAL COMPOUNDS FOR LOW CURRENT ELECTROCHROMIC DEVICES GENTEX CORPORATION (US) 2024-12-25 EP disclosed
US-12054486-B2 Pyridine derivatives and their use as sodium channel activators XENON PHARMACEUTICALS INC. (CA) 2024-08-06 US disclosed
WO-2024157916-A1 ETHYLENE PRODUCTION METHOD, CARBON DIOXIDE REDUCTION ELECTRODE, AND CARBON DIOXIDE REDUCTION APPARATUS 住友化学株式会社 2024-08-02 WO disclosed
CN-118284602-A Pyridine derivatives as sodium channel activators and uses thereof 泽农医药公司 2024-07-02 CN disclosed
CN-117843579-A Benzo heterocycle coupled catechol derivative and preparation method and application thereof 暨南大学 2024-04-09 CN disclosed
CN-117794960-A Hydrophilic copolymers and hydrophilic compositions 信越化学工业株式会社 2024-03-29 CN disclosed
US-4555553-A HIGH STRENGTH; HEAT RESISTANCE THE DOW CHEMICAL COMPANY (US) 1985-11-26 US disclosed
EP-0031296-B1 METHOD FOR THE PREPARATION OF BENZAZOLYL COMPOUNDS CIBA-GEIGY AG (CH) 1985-08-07 EP disclosed
US-4528381-A Process for making triazoles UNIROYAL, INC. (US) 1985-07-09 US disclosed
EP-0075459-A2 Process for making triazoles UNIROYAL, INC. (US) 1983-03-30 EP disclosed
US-4327209-A Process for the production of dibenzazolyl compounds CIBA-GEIGY CORPORATION (US) 1982-04-27 US disclosed
EP-0031296-A1 Method for the preparation of benzazolyl compounds CIBA-GEIGY AG (CH) 1981-07-01 EP disclosed
US-4138568-A NITRO-O-PHENYLENEDIAMINE, UREA, HALOBENZENE SOLVENT CIBA-GEIGY CORPORATION (US) 1979-02-06 US disclosed
US-3965092-A HEAT EXCHANGE, SURFACTANTS PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1976-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130211168-A1 CATALYTIC COMPOSITION AND PROCESS FOR OLIGOMERIZATION OF OLEFINS USING SAID CATALYTIC COMPOSITION AOC2, AOC3, ALOX15 ALDH1A1 507/4885KMT2A 1582/4885MEN1 1182/4885
US-12054486-B2 Pyridine derivatives and their use as sodium channel activators SCN1A, SCN1B, CACNA1A ALDH1A1 1317/4885KMT2A 2110/4885MEN1 1858/4885
US-20250059189-A1 PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS SCN1A, SCN1B, CACNA1A ALDH1A1 1432/4885KMT2A 2136/4885MEN1 1885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.